Want to see GB:HEMO full AI Analyst Report?

HemoGenyx Pharmaceuticals Plc (HEMO) Financial Statements

37 Followers

HemoGenyx Pharmaceuticals Plc Financial Overview

HemoGenyx Pharmaceuticals Plc's market cap is currently £30.90M. The company's EPS TTM is p-2.21; its P/E ratio is -1.98; HemoGenyx Pharmaceuticals Plc is scheduled to report earnings on April 30, 2026, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	£ 0.00	£ 0.00	£ 0.00	£ 0.00	£ 0.00
Gross Profit	£ -588.75K	£ -639.28K	£ -645.68K	£ -2.60M	£ -283.65K
Operating Income	£ -4.66M	£ -5.73M	£ -5.56M	£ 4.00M	£ -2.70M
EBITDA	£ -4.07M	£ -4.71M	£ -5.73M	£ -3.42M	£ -2.39M
Net Income	£ -9.76M	£ -5.62M	£ -6.69M	£ -3.98M	£ -5.10M
Balance Sheet
Cash & Short-Term Investments	£ 1.59M	£ 159.26K	£ 1.25M	£ 2.53M	£ 6.84M
Total Assets	£ 4.18M	£ 4.21M	£ 6.11M	£ 7.09M	£ 8.52M
Total Debt	£ 2.00M	£ 2.62M	£ 2.95M	£ 3.42M	£ 10.15K
Net Debt	£ 417.82K	£ 2.46M	£ 1.70M	£ 890.08K	£ -6.83M
Total Liabilities	£ 3.03M	£ 3.36M	£ 3.32M	£ 3.85M	£ 352.84K
Stockholders' Equity	£ 1.20M	£ 897.51K	£ 2.82M	£ 3.28M	£ 8.19M
Cash Flow
Free Cash Flow	£ -3.45M	£ -4.13M	£ -6.22M	£ -3.34M	£ -3.45M
Operating Cash Flow	£ -3.45M	£ -4.12M	£ -6.11M	£ -2.91M	£ -2.63M
Investing Cash Flow	£ -6.80K	£ -24.90K	£ -31.94K	£ -420.25K	£ -938.95K
Financing Cash Flow	£ 4.89M	£ 3.08M	£ 4.45M	£ -110.14K	£ 8.78M

Currency in GBP

HemoGenyx Pharmaceuticals Plc Earnings and Revenue History

Income Statement >

HemoGenyx Pharmaceuticals Plc Debt to Assets

Balance Sheet >

HemoGenyx Pharmaceuticals Plc Cash Flow

Cash Flow >

HemoGenyx Pharmaceuticals Plc Forecast EPS vs Actual EPS

Earnings >